Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
The anti-tumour efficacy of human recombinant interleukin 2. Correlation between sensitivity of tumours to the cytolytic effect of LAK cells in vitro and their susceptibility to interleukin 2 immunotherapy in vivo
J Bubeník, M Indrová
Folia Biologica
|
January 1, 1984
BW 5147 supernatants suppress Con A stimulation of mouse spleen cells
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1978
In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1988
Generation of LAK cells depends on the age of LAK cell precursor donors
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1981
Non T suppressor cells in the lymph nodes of mice bearing methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1984
Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations
M Indrová, J Bubeník
Immunology Letters
|
December 1, 1987
Cancer immunotherapy using local interleukin 2 administration
J Bubeník, M Indrová
Neoplasma
|
January 1, 1979
Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1979
Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1986
Immunotherapy of murine sarcomas with interleukin 2. II. Activation of killer cells by human recombinant IL-2
M Indrová, J Bubeník, A Toulcová
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
The anti-tumour efficacy of human recombinant interleukin 2. Correlation between sensitivity of tumours to the cytolytic effect of LAK cells in vitro and their susceptibility to interleukin 2 immunotherapy in vivo
J Bubeník, M Indrová
Folia Biologica
|
January 1, 1984
BW 5147 supernatants suppress Con A stimulation of mouse spleen cells
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1978
In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1988
Generation of LAK cells depends on the age of LAK cell precursor donors
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1981
Non T suppressor cells in the lymph nodes of mice bearing methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1984
Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations
M Indrová, J Bubeník
Immunology Letters
|
December 1, 1987
Cancer immunotherapy using local interleukin 2 administration
J Bubeník, M Indrová
Neoplasma
|
January 1, 1979
Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1979
Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas
M Indrová, J Bubeník
Folia Biologica
|
January 1, 1986
Immunotherapy of murine sarcomas with interleukin 2. II. Activation of killer cells by human recombinant IL-2
M Indrová, J Bubeník, A Toulcová
Page
of 6